Praxis Precision Medicines (PRAX) Amortization of Deferred Charges (2020 - 2026)

Praxis Precision Medicines' Amortization of Deferred Charges history runs 7 years deep, the most recent figure standing at $197000.0 for Q1 2026.

• On a quarterly basis, Amortization of Deferred Charges fell 20.88% year-over-year to $197000.0 in Q1 2026; TTM through Mar 2026 was $988000.0, a 3.13% increase from a year earlier, with the FY2025 full-year figure at $1.0 million, up 11.47% from the prior year.
• Amortization of Deferred Charges declined to $197000.0 in Q1 2026 per PRAX's latest filing, from $271000.0 in the prior quarter.
• Across five years, Amortization of Deferred Charges topped out at $271000.0 in Q4 2025 and bottomed at $180000.0 in Q1 2022.
• The 5-year median for Amortization of Deferred Charges is $218000.0 (2023), against an average of $221117.6.
• Across the five-year window, Amortization of Deferred Charges tumbled 59.31% in 2022 and gained 11.74% in 2025, its largest moves.
• Year by year, Amortization of Deferred Charges stood at $196000.0 in 2022, then rose by 11.22% to $218000.0 in 2023, then rose by 11.47% to $243000.0 in 2024, then gained by 11.52% to $271000.0 in 2025, then declined by 27.31% to $197000.0 in 2026.
• Per Business Quant, the three latest PRAX Amortization of Deferred Charges figures stand at $197000.0 (Q1 2026), $271000.0 (Q4 2025), and $263000.0 (Q3 2025).